Cleerly is a Denver-based digital healthcare company using FDA-cleared artificial intelligence to analyze coronary CT scans and non-invasively measure plaque, stenosis and the likelihood of ischemia in the heart's arteries. Founded in 2017 by cardiologist James K. Min, the company builds machine-learning software that turns a routine CCTA scan into a quantitative, vessel-by-vessel picture of coronary artery disease - aiming to catch atherosclerosis earlier and help physicians prevent heart attacks rather than react to them.
James K. Min is the founder and CEO of Cleerly, a Denver-based digital health company using AI to analyze coronary CT scans and detect atherosclerosis long before a heart attack strikes. A board-certified cardiologist who spent two decades in academic medicine, Min left a professorship at Weill Cornell and the directorship of the Dalio Institute of Cardiovascular Imaging to build a company that could deliver personalized, plaque-based heart evaluation at scale. He has authored more than 500 peer-reviewed papers, led landmark cardiac imaging trials, and raised hundreds of millions to push a shift from population-based cardiology toward individualized care.